Furthermore, we identify a lower expression of GM-CSF and IL-4 receptors by patients' monocytes, suggesting that the interaction of these cytokines and the cells may be less than optimal when patients' cells are involved, a phenomenon that could contribute to their affected phenotype and, likewise, to tumor escape. The gene discussed is CSF2; the disease is neoplasm.